Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single‐agent ibrutinib

Bleeding events have been observed among a subgroup of chronic lymphocytic leukaemia (CLL) patients treated with ibrutinib. We analysed data from two studies of single‐agent ibrutinib to better characterize bleeding events and pattern of anticoagulation and antiplatelet use. Among 327 ibrutinib‐trea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Haematol
Autors principals: Jones, Jeffrey A., Hillmen, Peter, Coutre, Steven, Tam, Constantine, Furman, Richard R., Barr, Paul M., Schuster, Stephen J., Kipps, Thomas J., Flinn, Ian W., Jaeger, Ulrich, Burger, Jan A., Cheng, Mei, Ninomoto, Joi, James, Danelle F., Byrd, John C., O'Brien, Susan M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Platelets, Haemostasis and Thrombosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084297/
https://ncbi.nlm.nih.gov/pubmed/28397242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars